Patel, P., Canonico, M., Hawkins, H., Zargari, M., Kennedy, K., Walsh, K., Mittlebeeler, E., Yelvington, B., Lee, L., Mason, E. F., Fedorov, K., Kishtagari, A., Mohan, S., Savona, M., Ball, S. (2025). Oral decitabine-cedazuridine versus parenteral hypomethylating agents in treatment-Naïve TP53-mutated Myelodysplastic Syndromes. Blood. https://doi.org/10.1182/blood-2025-7389